A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab
- PMID: 34563742
- DOI: 10.1016/j.jaip.2021.09.020
A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
